DiaMedica Therapeutics Inc. has granted stock options to a newly hired non-executive employee, providing the option to purchase 50,000 shares of the company’s common stock at an exercise price of $8.54 per share, matching the closing price on January 15, 2026. The options will vest with 25% becoming exercisable after one year from the grant date, and the remaining 75% vesting in 12 equal quarterly installments over the following three years, contingent on continued employment. The options have a ten-year term and were issued under DiaMedica’s Amended and Restated 2021 Employment Inducement Incentive Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DiaMedica Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260116177783) on January 16, 2026, and is solely responsible for the information contained therein.